Drug Bivalirudin Better Than Heparin After Heart Attack, Large Study Suggests

Heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors.

Read the whole article on Science Daily

More from Science Daily